SUBSCRIBE THIS CHANNEL BY PRESSING THIS BUTTON FOR BEING UPDATES FROM BIOMEDICAL AND HEALTHCARE SOCIETY HELLO GUYS, WELCOMING U ALL IN ANOTHER EPISODE OF WEEKLY TECH UPDATES . I AM AMIT AND U ARE WATCHING TECHOMED . SO ANY FURTHER DELAY LETS GET STARTED SO THE UPDATE IS ABOUT WORLD’S FIRST MRI COMPATABLE PATIENT MONITORING SYSTEM WHICH IS NOW FDA APPROVED IRADIMED being able to replace all magnetic components inside the monitor with non-magnetic ones that allows the device to be completely safe inside a 30,000 gauss magnetic field. Some of the features of the 3880 monitor according to IRADIMED: Wireless ECG with dynamic gradient filtering Wireless SpO2 using Masimo® algorithms Respiratory CO2 Non-invasive blood pressure Patient temperature Optional advanced multi-gas anesthetic agent unit featuring continuous Minimum Alveolar Concentration measurements THE ANOTHER UPDATE IS ABOUT APP BASED ULTRASOUND SYSTEM WHO IS NOW FDA APPROVED Healcerion based in South Korea, was the first company to receive FDA clearance for their wireless app-based ultrasound system back in 2015 The groundbreaking work done by South Korean engineers and scientists laid the foundation for the development of an ultrasound transducer that works with most smartphones or tablets ince introducing the SONON 300C convex transducer the company has been making progress to further advance this branch of ultrasound devices. Their latest, the SONON 300L linear transducer, weighs only 13 ounces (370 grams) including the battery, and features color doppler mode for easier musculoskeletal (MSK), vascular, small parts (breast, thyroid) lung imaging, and much more.The SONON series can be used to connect and transmit through Wi-Fi as well as 3G/LTE, so doctors always have an Internet connection, even in many remote regions of the world Its size, weight, and capabilities, along with the three hour scan time make it perfect for emergency and everyday use The FDA approval for SONON 300L shows that app-based ultrasound is continuing to move forward While it cannot yet replace conventional full-size ultrasound systems, it’s important to remember that computers used to take up whole rooms too, but now smartphones are even more powerful than those behemoths once were. MOVING TOWARDS THE NEXT UPDATE IS ABOUT THE CHEMO TESTING THROUGH MICROFLUIDIC DEVICE Chemotherapy can be very difficult on patients but finding out that the cancer didn’t respond to the chemo is even more disturbing Soon there may be a way to try different chemo agents on a patient’s own tumor cells taken during a biopsy. Researchers at Purdue University have developed a microfluidic system inside which tumor cells can be exposed to therapeutic agents.The device, dubbed tumor-microenvironment-on-chip (T-MOC), is about two inches (4.5 centimeters) on a side Inside, tumor cells are grown in a special matrix, resulting in a relatively natural, 3D environment The interstitial fluid that flows between tumor cells is also added to best recreate the typical tissue environment. Moreover, the team introduced simulated pharmacokinetics of liver and kidneys to the System clearing out the chemo agent and reducing its concentration, just like the body normally would. The researchers tested the device at detecting how well doxorubicin, a common chemo agent, worked on two breast cancer types. They did the same with breast cancer mouse models and demonstrated that the microfluidic device is as good as animals for this kind of work. More work needs to be done on different cancer types, as well as larger studies, but perhaps one day oncologists will have a much easier time selecting which chemotherapy to apply. The next Bio-Tech update is from Acutus who’s tech is fully ultrasound based which gives the images of our inside heart. Acutus Medical, a California based company won FDA clearance for its AcQMap High Resolution Imaging and Mapping System as well as the accompanying AcQMap 3D Imaging and Mapping Catheter. The catheter uses ultrasound and more traditional electrical tissue conduction mapping to create a unique live view inside the heart hat combines the physical mechanics of the organ with its electrical activity. This should be particularly useful during cardiac ablation procedures when monitoring the heart’s response to treatment.The AcQMap System is able to provide global dipole density mapping of irregular and chaotic activation in the atrial chambers whereas conventional sequential mapping may struggle to provide us with the information that is required. In the cases we have performed thus far, real-time mapping of complex arrhythmias A revolutionary Tech update is about the serious wound Treatment using electric fields & ultrasounds. BRH Medical Israel based company won FDA clearance for its BRH-A2 system that uses ultrasound and electricity to heal deep and chronic wounds. Using the two methods allows to speed up the healing of the wound while reducing pain during treatment. Both electric fields and ultrasound energy are delivered into and under the wound, treating it from all sides To cover a wide range of treatment options in one session, the device varies the frequency and strength of the electric and ultrasound stimulations. The device can be used in combination with other therapeutic methods, such as negative pressure therapy Since most patients receive multiple treatments, the device includes a patient and wound management system for keeping track of how things are progressing over time. It can also be used to measure ulcers, including ones with poorly defined edges. Another updates is about the use of AR in the lymph Node removal therapy Lymph nodes are common pathways for certain cancers to spread, requiring surgical removal. These days lymph nodes are visualized using gamma ray imagers that spot the radioactive Technetium-99m tracer that’s injected near a tumor. This is a slow process that exposes patients to a good deal of radiation, but augmented reality (AR) technology may help overcome this. Researchers from a university in Germany has developed a system that uses indocyanine green (ICG) fluorescent dye as a non-radioactive tracer that is spotted using infrared cameras and augmented reality glasses.
The ICG dye is injected to seep into affected lymph nodes. It is then It is then excited using infrared light, making it glow in the near-infrared spectrum ever so slightly. 3D near-infrared cameras pick up this glow and with the aid of mapping and navigation software, project the location of the glow inside a pair of glasses worn by the surgeon. This projected glow lines up perfectly with the location of the fluorescent dye, giving the surgeon a clear view of what needs to be excised. so that’s all about the tech updates from the biomedical society and healthcare society this week. if u have any query or suggestion u can give it in comment section. Do like this video, share this video with others & don’t Forget to subscribe this channel Coz i used to come up with various tech updates from biomedical and healthcare society weekly So , This is Amit Mohan Raman Signing Out.